These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17885757)

  • 41. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.
    Ohta M; Nagai H; Shimizu M; Rasio D; Berd D; Mastrangelo M; Singh AD; Shields JA; Shields CL; Croce CM
    Cancer Res; 1994 Oct; 54(20):5269-72. PubMed ID: 7923152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
    Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
    JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of INK4a/Arf locus-encoded senescent checkpoints activated in normal and psoriatic keratinocytes.
    Chaturvedi V; Cesnjaj M; Bacon P; Panella J; Choubey D; Diaz MO; Nickoloff BJ
    Am J Pathol; 2003 Jan; 162(1):161-70. PubMed ID: 12507899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sinonasal mucosal melanoma: Molecular profile and therapeutic implications from a series of 32 cases.
    Turri-Zanoni M; Medicina D; Lombardi D; Ungari M; Balzarini P; Rossini C; Pellegrini W; Battaglia P; Capella C; Castelnuovo P; Palmedo G; Facchetti F; Kutzner H; Nicolai P; Vermi W
    Head Neck; 2013 Aug; 35(8):1066-77. PubMed ID: 22791410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
    Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
    Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.
    Abdel-Rahman MH; Pilarski R; Massengill JB; Christopher BN; Noss R; Davidorf FH
    Melanoma Res; 2011 Jun; 21(3):175-9. PubMed ID: 21412176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BRAF alterations are associated with complex mutational profiles in malignant melanoma.
    Daniotti M; Oggionni M; Ranzani T; Vallacchi V; Campi V; Di Stasi D; Torre GD; Perrone F; Luoni C; Suardi S; Frattini M; Pilotti S; Anichini A; Tragni G; Parmiani G; Pierotti MA; Rodolfo M
    Oncogene; 2004 Aug; 23(35):5968-77. PubMed ID: 15195137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutual exclusivity analysis of genetic and epigenetic drivers in melanoma identifies a link between p14 ARF and RARβ signaling.
    Dahl C; Christensen C; Jönsson G; Lorentzen A; Skjødt ML; Borg Å; Pawelec G; Guldberg P
    Mol Cancer Res; 2013 Oct; 11(10):1166-78. PubMed ID: 23851445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma.
    Brown VL; Harwood CA; Crook T; Cronin JG; Kelsell DP; Proby CM
    J Invest Dermatol; 2004 May; 122(5):1284-92. PubMed ID: 15140233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion.
    Takata M; Lin J; Takayanagi S; Suzuki T; Ansai S; Kimura T; Cerroni L; Saida T
    Br J Dermatol; 2007 Jun; 156(6):1287-94. PubMed ID: 17535228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of human tissue to assess the oncogenic activity of melanoma-associated mutations.
    Chudnovsky Y; Adams AE; Robbins PB; Lin Q; Khavari PA
    Nat Genet; 2005 Jul; 37(7):745-9. PubMed ID: 15951821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma.
    Hutchinson KE; Johnson DB; Johnson AS; Sanchez V; Kuba M; Lu P; Chen X; Kelley MC; Wang Q; Zhao Z; Kris M; Berger MF; Sosman JA; Pao W
    Oncotarget; 2015 Sep; 6(26):22348-60. PubMed ID: 26084293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
    Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma.
    Shields JM; Thomas NE; Cregger M; Berger AJ; Leslie M; Torrice C; Hao H; Penland S; Arbiser J; Scott G; Zhou T; Bar-Eli M; Bear JE; Der CJ; Kaufmann WK; Rimm DL; Sharpless NE
    Cancer Res; 2007 Feb; 67(4):1502-12. PubMed ID: 17308088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
    Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
    J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in targeted therapy for melanoma.
    Friedlander P; Hodi FS
    Clin Adv Hematol Oncol; 2010 Sep; 8(9):619-27. PubMed ID: 21157411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
    Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
    Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.